M. Reiser

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

N/A

0Author DataRank · unranked

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “FluCam—a New, 4-Weekly Combination of Fludarabine and Alemtuzumab for Patients with Relapsed Chronic Lymphocytic Leukemia.”.

FluCam—a New, 4-Weekly Combination of Fludarabine and Alemtuzumab for Patients with Relapsed Chronic Lymphocytic Leukemia.

Blood(2004)10.1182/blood.v104.11.2517.2517

N/A

0.330DataRank · unranked

8 citations

P. Bochmann, H. Schulz, M. Reiser, S. Trelle, P. Staib +4 more

Erste Erfahrungen mit gepulster Durchleuchtung an einer multifunktionellen Durchleuchtungsanlage

RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren(1996)10.1055/s-2007-1015793

N/A

0.312DataRank · unranked

7 citations

T. Helmberger, T. Waggershauser, M. Schätzl, H. Allmendinger, M. Reiser +1 more